Chong Yu to Pulmonary Disease, Chronic Obstructive
This is a "connection" page, showing publications Chong Yu has written about Pulmonary Disease, Chronic Obstructive.
Connection Strength
1.251
-
Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease. Respir Res. 2019 Apr 05; 20(1):69.
Score: 0.223
-
Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan. Int J Chron Obstruct Pulmon Dis. 2018; 13:3055-3063.
Score: 0.215
-
MMP-12 activates protease-activated receptor-1, upregulates placenta growth factor, and leads to pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol. 2018 09 01; 315(3):L432-L442.
Score: 0.209
-
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist. Int J Chron Obstruct Pulmon Dis. 2017; 12:2477-2485.
Score: 0.199
-
Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality. PLoS One. 2017; 12(4):e0175794.
Score: 0.194
-
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers. Crit Care Med. 2019 01; 47(1):e14-e20.
Score: 0.055
-
Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients. J Formos Med Assoc. 2019 Jan; 118(1 Pt 3):429-435.
Score: 0.053
-
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:867-874.
Score: 0.052
-
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12:2987-2996.
Score: 0.050